BioSpace News Archive

BioMidwest

Inspired Spine provides safe and effective spine surgery options at Ambulatory Surgery Centers: A reliable alternative to prevent permanent neurological damage while enabling hospitals to prepare for COVID-19;

Within the last week, many Americans who are afflicted with chronic back pain have been informed their back surgery has been canceled due to COVID-19.

March 20, 2020
·
2 min read
Pharm Country

Amneal Accelerates Distribution and Production of Hydroxychloroquine Sulfate to Meet Potential Needs of COVID-19 Patients Nationwide

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”), one of the largest U.S.-based generics manufacturers, today announced that it is responding to the national COVID-19 health emergency by building on its existing supply of hydroxychloroquine sulfate.

March 20, 2020
·
4 min read
BioMidwest

Banyan Pledges $1 Million to Enable over 100 Patient Isolation Rooms with Virtual Care

Banyan’s TAP4H program protects medical staff from COVID-19 while providing best possible care to patients

March 20, 2020
·
3 min read
Biotech Bay

Nurx Launches First COVID-19 Home Testing & Online Consultation Service

Leading health tech company is the first to introduce novel approach to addressing the COVID-19 pandemic

March 20, 2020
·
6 min read
Policy

Prime Minister announces temporary border agreement with the United States

COVID-19 continues to evolve rapidly, and the Government of Canada is working around the clock to limit its spread and do everything necessary to protect the health and safety of Canadians.

March 20, 2020
·
6 min read
Pharm Country

Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer

Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, has been notified that TRC Capital Investment Corporation (TRC Capital) has commenced an unsolicited “mini-tender” offer, dated March 26, 2020, to purchase up to 1,500,000 shares of Merck common stock at $73.35 per share

March 20, 2020
·
5 min read
BioMidwest

Microbiologics Introduces the First SARS-CoV-2 RNA IVD CE Marked Control

To help accelerate COVID-19 assay development and increase access to testing, Microbiologics is launching a SARS-CoV-2 IVD control within its popular Helix EliteTM line of molecular controls.

March 20, 2020
·
2 min read
Policy

Coronavirus (COVID-19) Update: FDA Alerts Consumers About Unauthorized Fraudulent COVID-19 Test Kits

The following statement is attributed to Commissioner Stephen M. Hahn M.D., and Associate Commissioner for Regulatory Affairs Judith A. McMeekin, Pharm.D.

March 20, 2020
·
2 min read
Biotech Bay

Forward Announces Launch of COVID-19 Home Testing Kits

With the offering of its first at-home testing kit, Forward expands COVID-19 testing options to scale its ability to treat the growing population experiencing the barricades of an overwhelmed healthcare system

March 20, 2020
·
4 min read